| Blood–brain barrier dysfunction in parkinsonian midbrain in vivo R Kortekaas, KL Leenders, JCH Van Oostrom, W Vaalburg, J Bart, ... Annals of neurology 57 (2), 176-179, 2005 | 836 | 2005 |
| Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer AN Niemeijer, D Leung, MC Huisman, I Bahce, OS Hoekstra, ... Nature communications 9 (1), 4664, 2018 | 404 | 2018 |
| Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs AAM Van der Veldt, M Lubberink, I Bahce, M Walraven, MP de Boer, ... Cancer cell 21 (1), 82-91, 2012 | 366 | 2012 |
| The blood-brain barrier and oncology: new insights into function and modulation J Bart, HJM Groen, NH Hendrikse, WTA Van der Graaf, W Vaalburg, ... Cancer treatment reviews 26 (6), 449-462, 2000 | 252 | 2000 |
| The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood–testis barrier and in primary testicular tumours J Bart, H Hollema, HJM Groen, EGE De Vries, NH Hendrikse, DT Sleijfer, ... European journal of cancer 40 (14), 2064-2070, 2004 | 212 | 2004 |
| An oncological view on the blood–testis barrier J Bart, HJM Groen, WTA Van Der Graaf, H Hollema, NH Hendrikse, ... The lancet oncology 3 (6), 357-363, 2002 | 211 | 2002 |
| Complete in vivo reversal of P‐glycoprotein pump function in the blood‐brain barrier visualized with positron emission tomography NH Hendrikse, AH Schinkel, EGE De Vries, E Fluks, WTA Van der Graaf, ... British journal of pharmacology 124 (7), 1413-1418, 1998 | 209 | 1998 |
| PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS PH Elsinga, NH Hendrikse, J Bart, W Vaalburg, A Waarde Current pharmaceutical design 10 (13), 1493-1503, 2004 | 203 | 2004 |
| Visualization of multidrug resistance in vivo NH Hendrikse, EJF Franssen, WTA Van der Graaf, W Vaalburg, ... European journal of nuclear medicine 26, 283-293, 1999 | 202 | 1999 |
| A New in Vivo Method to Study P-Glycoprotein Transport in Tumors and the Blood-Brain Barrier NH Hendrikse, EGE De Vries, L Eriks-Fluks, WTA Van Der Graaf, ... Cancer research 59 (10), 2411-2416, 1999 | 187 | 1999 |
| 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein NH Hendrikse, EJF Franssen, WTA Van der Graaf, C Meijer, DA Piers, ... British journal of cancer 77 (3), 353-358, 1998 | 186 | 1998 |
| Immuno-positron emission tomography with zirconium-89-labeled monoclonal antibodies in oncology: what can we learn from initial clinical trials? YWS Jauw, CW Menke-van der Houven van Oordt, OS Hoekstra, ... Frontiers in pharmacology 7, 131, 2016 | 165 | 2016 |
| Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET PH Elsinga, EJF Franssen, NH Hendrikse, L Fluks, AMA Weemaes, ... Journal of Nuclear Medicine 37 (9), 1571-1575, 1996 | 143 | 1996 |
| Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status I Bahce, EF Smit, M Lubberink, AAM van der Veldt, M Yaqub, ... Clinical Cancer Research 19 (1), 183-193, 2013 | 141 | 2013 |
| Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients AAM Van Der Veldt, NH Hendrikse, EF Smit, MPJ Mooijer, AY Rijnders, ... European journal of nuclear medicine and molecular imaging 37, 1950-1958, 2010 | 124 | 2010 |
| In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically K Ishiwata, K Kawamura, K Yanai, NH Hendrikse Journal of Nuclear Medicine 48 (1), 81-87, 2007 | 117 | 2007 |
| Quantitative assessment of P-glycoprotein function in the rat blood–brain barrier by distribution volume of [11C] verapamil measured with PET J Bart, ATM Willemsen, HJM Groen, WTA Van Der Graaf, TD Wegman, ... Neuroimage 20 (3), 1775-1782, 2003 | 112 | 2003 |
| Radiopharmaceuticals R Lange, N Schreuder, H Hendrikse Practical Pharmaceutics: An International Guideline for the Preparation …, 2023 | 101 | 2023 |
| In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein NH Hendrikse, F Kuipers, C Meijer, R Havinga, CMA Bijleveld, ... Cancer chemotherapy and pharmacology 54, 131-138, 2004 | 82 | 2004 |
| Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia:: A PET study with [11C] verapamil as a probe for P-glycoprotein … OL de Klerk, ATM Willemsen, FJ Bosker, AL Bartels, NH Hendrikse, ... Psychiatry Research: Neuroimaging 183 (2), 151-156, 2010 | 80 | 2010 |
